Pfizer’s antiviral COVID-19 pill approved by U.K. regulators – National

Great Britain has approved Pfizer’s COVID-19 contraceptive pill for patients over 18 years of age who have mild to moderate infection and are at greater risk of exacerbation of their disease.

The approval comes as the country seeks to build up its defenses amid a record daily record of new COVID-19 cases. On Thursday, government data showed a spike in COVID-19 cases.

The British Medicines and Healthcare products Regulatory Agency (MHRA) said on Friday that the contraceptive pill, Paxlovid, is most effective when taken during the early stages of COVID-19, based on the data, and recommended that the drug be used within five days of the onset of the virus. symptoms.

Read more:

Pfizer COVID-19 Oral Pills FDA Approved for Home Use

Pfizer said this month that Baxlovid has been shown to be nearly 90 percent effective in preventing hospitalization and death in high-risk patients, and recent laboratory data indicates that the drug retains efficacy against the rapidly spreading Omicron variant of the coronavirus.

The story continues below the ad

“We now have another antiviral drug to treat COVID-19 that can be taken orally rather than given intravenously. This means it can be administered outside a hospital setting,” MHRA President John Rehn said in a statement.

Click to play the video:

Canada signs agreements on 1.5 million cycles of Pfizer, Merck COVID-19 antiviral pills

Canada signs agreements for 1.5 million cycles of antiviral pills from Pfizer and Merck COVID-19 – December 3, 2021

Canadian health regulators continue to review the treatment for use in the country.

View link »


Leave a Comment